Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core outcome set for the evaluation of clinical therapeutic interventions for human leptospirosis. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-024-08713-6
PubMed Identifier: 39762892
Publication URI: http://europepmc.org/abstract/MED/39762892
Type: Journal Article/Review
Volume: 26
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215